补肾活血方对PCO小鼠未成熟卵母细胞体外核成熟的影响

目的 探讨补肾活血方对PCO小鼠未成热卵母细胞体外核成熟的影响.方法 (1)制备补肾活血方含药血清:(2)制作PCO小鼠模型;(3)将PCO小鼠生发泡(germinal vesicle,GV)期卵母细胞分别在不同采血时间获取的补肾活血方含药血清培养液中进行体外培养,观察补肾活血方含药血清对生发泡破裂(germinal vesicle break-down,GVBD)和第一极体(the first polar body,PB1)排出的时效关系.结果 (1)2 h和2.5 h药物血清组卵母细胞GVBD的发生率高于正常血清组和对照组,培养后4 h差异有统计学意义(P<0.01);(2)2 h和2.5 h药物血清组卵母细胞PB1的发生率高于正常血清组和对照组,培养后18 h差异有统计学意义(P<0.01).结论 2～2.5 h补肾活血方舍药血清对PCO小鼠未成熟卵母细胞体外核成熟具有明显促进作用.     

表皮生长因子对小鼠卵母细胞体外成熟的影响

目的 探讨表皮生长因子(epidermal growth factor,EGF)对小鼠卵母细胞体外成熟及受精的作用.方法 在体外成熟液中分别添加0、0.1、1、5、10ng/Mlegf,12h后检查成熟率,并观察EGF对体外受精的影响.结果 添加5ng/Ml和10ng/Mlegf组卵母细胞第一极体排出率较对照组显著提高(P<0.05),并且5ng/Ml组的效果显著高于其他各组(P<0.05);比较培养液中添加以上浓度EGF对体外受精胚发育的影响,结果发现添加5ng/Ml EGF虽不能显著提高囊胚发育率(P>0.05),但可显著提高其通过二细胞阻滞率和囊胚孵化率(P<0.01).结论 EGF对小鼠卵母细胞体外成熟及受精有促进作用,可提高体外成熟率及囊胚孵化率,还可促进受精卵通过二细胞阻滞.     

小鼠生殖泡期卵母细胞体外培养成熟、受精和胚胎发育的研究

为研究性成熟小鼠生殖泡期(GV)卵母细胞的体外成熟,同时比较体外成熟(IVM)和体内成熟组卵子的受精、胚胎发育情况,机械法分离性成熟小鼠卵巢中的GV期卵母细胞及刺激后的成熟卵母细胞,直接培养于[α-MEM+1 mg/ml Fetuin+10％FCS+1.5 IU/ml rHCG±5 ng/mlrEGF]中,16 h后移入f-HTF+10％FCS体外受精4 h,再在M16+10％FCS中培养72 h。记录其成熟、受精和胚胎发育情况,并与体内成熟的卵子比较。结果:GV期卵母细胞在含HCG培养液中成熟率为89.68％,培养液中添加EGF后,卵子成熟率无显著上升,但受精率、卵裂率均有显著提高(P<0.05)。体内成熟卵子的受精率可达62.83％,卵裂率60.18％;IVM组受精率仅48.92％,卵裂率36.69％,明显低于前者(P<0.01)。结论:小鼠GV期卵母细胞可体外培养成熟、受精和胚胎发育。培养液中添加促性腺激素和EGF都促进卵母细胞体外成熟、受精和胚胎发育能力。但IVM组卵母细胞的受精率、卵裂率低于体内成熟组,培养系统仍需改进。     

金雀异黄素对雌性小鼠卵母细胞成熟及其受精能力的影响

目的:探讨金雀异黄素(Gen)对小鼠卵母细胞成熟的影响.方法:用不同浓度的Gen给小鼠腹腔注射后,检测Gen对卵母细胞生发泡破裂(GVBD)、第一极体(PB1)释放、体外受精和胚胎发育等的影响;用含不同浓度的Gen的培养液培养小鼠未成熟卵母细胞,观察卵母细胞GVBD、PB1释放的发生率;结果:腹腔注射Gen可以增加小鼠子宫湿重,增加小鼠的超排卵数(除高剂量组外)、影响卵母细胞体内成熟过程中的GVBD和第一极体的释放(Gen-0.5组除外),高剂量组小鼠成熟卵母细胞的受精能力和胚胎发育能力均下降.Gen以剂量依赖的方式抑制体外培养小鼠未成熟卵母细胞的GVBD和PB1的释放.结论:Gen能够可逆性地抑制小鼠未成熟卵母细胞的成熟,高剂量的Gen可能影响卵母细胞减数分裂过程,降低卵母细胞的受精能力,提示育龄妇女摄人过量Gen及其化合物可能会导致生育能力降低,甚至造成不育或不孕.     

氯化锌对小鼠卵母细胞体外成熟的影响

目的探讨氧化锌对小鼠卵母细胞体外成熟的影响。方法采用细胞体外培养的方法,观察卵母细胞在分别含有低、中、高浓度(0μg/ml、1μg/ml、10μg/ml)氯化锌的M199培养液中体外成熟率和减数分裂的变化情况。结果1μg/mlZnCl2组GVBD发生率在4、8h明显高于对照组(P<0.01),16、24h高于对照组(P<0.05);而10μg/mlZnCl2组GVBD发生率在各时间点均明显低于对照组(P<0.01)。8h后,1μg/mlZnCl2组PB1排出率明显高于对照组(P<0.05),而10μg/mlZnCl2组PB1排出率明显低于对照组(P<0.05)。结论锌对体外小鼠卵母细胞成熟和减数分裂有重要的影响。     

NO对小鼠卵母细胞及胚胎发育的影响

目的 评价外源性NO对小鼠卵母细胞体内成熟、体外受精及胚胎发育的影响. 方法受试雌性小鼠超排卵期间分别腹腔注射NO供体硝普钠(SNP)1.0、5.0和10.0 mg/kg,对照组雌性小鼠注射等量的生理盐水.注射hCG 15 h后处死小鼠,收集卵母细胞进行体外受精和胚胎培养,观察卵母细胞的成熟度、受精率、早期胚胎的发育能力及其形态学变化.结果 5.0 mg/kg SNP组M Ⅰ期卵母细胞和M Ⅱ期卵母细胞的比例较对照组和1.0 mg/kg SNP组升高(P＜0.05,P＜0.01),而受精率降低(P＜0.01),10.0 mg/kg SNP组小鼠在注射药物20 min后全部死亡;5.0 mg/kg SNP组2-细胞胚胎以后各阶段胚胎的卵裂率低于对照组和1.0 mg/kg SNP组(P＜0.01),并被阻滞在桑葚胚期;5.0 mg/kg SNP组形态异常胚胎的比例高于对照组和1.0 mg/kg SNP组(P＜0.01).结论 较高浓度NO抑制卵母细胞体内成熟、体外受精及早期胚胎发育并影响胚胎的质量.     

人卵泡液中白血病抑制因子浓度及其对卵母细胞发育的影响

目的: 探讨人卵泡液中是否存在白血病抑制因子(LIF)及其对卵母细胞发育的影响. 方法: 采用ELISA法检测66例体外受精-胚胎移植患者取卵日卵泡液及其血清中LIF浓度,分析卵泡液中LIF浓度与卵母细胞发育的关系. 结果: 66份卵泡液中LIF浓度为(28.5±13.1) ng/L, 血清LIF浓度为(3.0±1.5) ng/L ,差异非常显著(P＜0.01),而且两者间无相关性(r=0.1915, P＞0.05). 含成熟卵母细胞的卵泡液中LIF浓度为(33.7±11.1)ng/L,含未成熟卵母细胞的卵泡液LIF浓度为(18.0±10.5)ng/L,两者比较差异非常显著(P＜0.01). 结论: 卵泡液中存在较高浓度的LIF,其对卵母细胞发育有促进作用.     

蔗糖浓度对GV和MⅡ期冻融卵母细胞纺锤体结构的影响

目的 探讨蔗糖浓度对GV期和MⅡ期冻融卵母细胞纺锤体质量的影响.方法 运用纺锤丝观测仪(PolScope)、免疫荧光标记技术和激光共聚焦显微镜.对不同蔗糖浓度(0.1-0.6 mol/L)下GV期和MⅡ期冻融卵母细胞体外成熟后的纺锤体分别进行检测,以未冷冻处理的卵母细胞作为对照组.结果 与对照组比较,冻融组卵母细胞纺锤体的排列明显受到影响.蔗糖浓度为0.3 mol/L时,GV期冻融组卵母细胞纺锤体的正常率最高(P＜0.05);蔗糖浓度为0.5 moL/L时,MⅡ期冻融组卵母细胞纺锤体的正常率最高(P＜0.05);当蔗糖浓度继续升高时,冻融组GV期和MⅡ期卵母细胞纺锤体的正常率则显著下降(P＜0.05).冻融组卵母细胞纺锤体的正常率,MⅡ期显著高于GV期(P＜0.05).结论 一定浓度范围的蔗糖可提高冻融卵母细胞纺锤体正常率;MⅡ期冻融卵母细胞的渗透耐受性及其在渗透耐受范围内的冷冻效率均高于GV期卵母细胞.     

蔗糖浓度对GV和MⅡ期冻融卵母细胞纺锤体结构的影响

目的 探讨蔗糖浓度对GV期和MⅡ期冻融卵母细胞纺锤体质量的影响.方法 运用纺锤丝观测仪(PolScope)、免疫荧光标记技术和激光共聚焦显微镜.对不同蔗糖浓度(0.1-0.6 mol/L)下GV期和MⅡ期冻融卵母细胞体外成熟后的纺锤体分别进行检测,以未冷冻处理的卵母细胞作为对照组.结果 与对照组比较,冻融组卵母细胞纺锤体的排列明显受到影响.蔗糖浓度为0.3 mol/L时,GV期冻融组卵母细胞纺锤体的正常率最高(P＜0.05);蔗糖浓度为0.5 moL/L时,MⅡ期冻融组卵母细胞纺锤体的正常率最高(P＜0.05);当蔗糖浓度继续升高时,冻融组GV期和MⅡ期卵母细胞纺锤体的正常率则显著下降(P＜0.05).冻融组卵母细胞纺锤体的正常率,MⅡ期显著高于GV期(P＜0.05).结论 一定浓度范围的蔗糖可提高冻融卵母细胞纺锤体正常率;MⅡ期冻融卵母细胞的渗透耐受性及其在渗透耐受范围内的冷冻效率均高于GV期卵母细胞.     

二至天癸颗粒对超排卵小鼠GDNF、GFR-1的影响

目的:从卵母细胞生殖泡裂解(GVBD)、第一极体的排出(PB1)的角度,探讨二至天癸颗粒改善卵母细胞质量及优胚率的可能机制。方法:将165只小鼠随机分为空白组、治疗组及对照组。治疗组及对照组用注射用尿促性素(HMG)和注射用绒促性素(HCG)超排卵,连续灌胃给药(治疗组用二至天癸颗粒,对照组用等量生理盐水),空白组无超排卵及灌胃给药等治疗。3组又各分为1、2两组。治疗组与对照组腹腔注射HMG 48 h后,空白组于动情周期当天,全部1组脱颈处死小鼠,取GV期DOs,观察PB1排出,收集卵母细胞,之后成熟卵母细胞行胶质细胞源性神经营养因子(GDNF)、家族特异性受体a-1(GFR-1)mRNA的表达检测。治疗组与对照组2组5只小鼠腹腔注射HCG10 IU,按雌∶雄=1∶1比例分别合笼饲养,合笼次日作为妊娠第1天。取受精卵,观察卵裂率、成胚率。空白组于确定发现阴道动情周期当天为第0天,即合笼,第2天晨发现阴道栓后,取受精卵,观察卵裂率、成胚率。结果:治疗组GV期卵母细胞GVBD率、PB1排出率均高于对照组,差异有统计学意义(P0.05);小鼠受精卵卵裂率及成胚率,治疗组与对照组比较,差异有统计学意义(P0.05)。治疗组卵母细胞GFR-1mRNA的表达明显高于对照组(P0.05)。结论:二至天癸颗粒提高小鼠卵母细胞GFR-1mRNA的表达,促进卵母细胞GVBD和PB1的排出,改善了卵母细胞成熟度,提高卵细胞质量,从而提高胚胎质量。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.